Results 231 to 240 of about 82,694 (258)

Clinical significance of renal histological diagnosis in patients with type 2 diabetes and proteinuria atypical for diabetic nephropathy

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 781-790, May 2026.
ABSTRACT Background/Aim Most patients with proteinuria are considered to have typical diabetic nephropathy (DN). However, when proteinuria occurs without diabetic retinopathy, with hematuria, or persists despite strict glycemic and blood pressure control, it is considered atypical for DN and warrants further evaluation for non‐DN via kidney biopsy ...
Shogo Kuwagata, Masami Chin‐Kanasaki, Aki Yamada, Tomonori Sakae, Nahomi Ishimoto, Yoshimi Imamura‐Uehara, Kosuke Yamahara, Mako Yasuda‐Yamahara, Sho Sugahara, Yuki Tanaka‐Sasaki, Natsumi Kuwata, Kimihiro Nishimura, Koichiro Murata, Itsuko Miyazawa, Shogo Ida, Natsuko Ohashi, Shinji Kume   +16 more
wiley   +1 more source

Predictive ability of serum osmolarity for contrast-induced nephropathy after elective percutaneous coronary intervention: Are we having a new target? [PDF]

Egypt Heart J
Samir A, Radwan A, Elhossary H, Baghdady Y.   +3 more
europepmc   +1 more source

Contrast-Induced Nephropathy in Endovascular Patients: A Retrospective Cohort Study from a Vascular Surgery Clinic in Eastern Europe. [PDF]

J Clin Med
Olariu N, Maralescu FM, Bob F, Grosu ID, Dragota-Pascota R, Marc L, Chisavu L, Albai O, Ratiu IA, Barac S, Rață AL, Mzi A, Mihaescu A.   +12 more
europepmc   +1 more source

Furosemide's Preventative Role in Contrast-Induced Nephropathy among ST-Segment Elevation Myocardial Infarction Patients undergoing Percutaneous Coronary Intervention. [PDF]

Adv Biomed Res
Ariafar M, Ghorbani P, Seyedian SM, Ahamdi F, Sabetnia L, Farhadi E.   +5 more
europepmc   +1 more source

Machine learning algorithms using the inflammatory prognostic index for contrast-induced nephropathy in NSTEMI patients. [PDF]

Biomark Med
Şaylık F, Çınar T, Selçuk M, Tanboğa İH.   +3 more
europepmc   +1 more source

Efficacy of atorvastatin on renal function in patients with contrast-induced nephropathy after percutaneous coronary intervention. [PDF]

J Cardiothorac Surg
Li H, Wang H, Ren S, Zhou R.
europepmc   +1 more source

Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Badreldin H, Mallya Prabhakar P.
europepmc   +1 more source

Protective effect of pentoxifylline on contrast induced nephropathy

Saudi Journal of Kidney Diseases and Transplantation, 2008
Roozbeh Jamshid, Jahromi Alireza, Sharifian Maryam, Pakfetrat Maryam, Afshariani Raha   +4 more
doaj  

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

Lancet, The, 2023
Vladimir Tesar, Hernan Trimarchi, Heather N Reich   +2 more
exaly  

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Lancet, The, 2023
Hiddo J Lambers Heerspink, Radko Komers, Michelle N Rheault   +2 more
exaly